CALR and glioblastoma: As retinoic acid signaling enhances differentiation and temozolomide sensitivity of GBM cells, a simultaneous decrease in CH60/HSPD1/HSP60 and calreticulin may enhance differentiation and growth suppression in GBM.29, 33